CaroGoMenno… Menopause!?!
Johannes W. DietrichReal-world data confirm the benefit of continuous glucose monitoring (#CGM), as presented in Chantal Mathieu's opening lecture at #ATTD23 #ATTD https://pubmed.ncbi.nlm.nih.gov/33780640/
Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World Study - PubMed
<span><b><i>Objective:</i></b> Achieving good metabolic control in people with type 1 diabetes (T1D) remains a challenge, despite the evolutions in diabetes technologies over the past decade. Here we investigate the evolution of metabolic control in people with T1D, where care is provided by specialized c</span> …
BirdflyRT @CaroGoLoop: Arrived in Barcelona! Let's start with the incredible opportunity to attend #ATTD2022 and learn about new developments in #diabetes technologies! @dedocDE will launch the first #dedoc simposium at #ATTD! Make sure to join via fb or the dedoc website! https://t.co/zwbpZ82BjC
RT @nerdabetic: #smartpens I love innovation in pen (MDI) technology as the vast majority of T1s use MDI. This is new pen from @novonordisk which has NFC and can transfer information about injections to @diasend . NovoNordisk also has partnerships with @Roche @mysugr @dexcom #ATTD2019 #attd https://t.co/qtuA0KpJen
Nerdabetic on Twitter
“#smartpens I love innovation in pen (MDI) technology as the vast majority of T1s use MDI. This is new pen from @novonordisk which has NFC and can transfer information about injections to @diasend . NovoNordisk also has partnerships with @Roche @mysugr @dexcom #ATTD2019 #attd https://t.co/qtuA0KpJen”